Insider · CIK 0001860609
Sushil Patel
Files at RVMD (Revolution Medicines, Inc.), REPL (Replimune Group, Inc.). First filing Nov 4, 2024, latest May 22, 2025.
Where the trades landed
Last year at the 2 companies this insider has traded most, with each buy and sell on the bar it happened.
REPL: Replimune Group, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
RVMD: Revolution Medicines, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 52Moderate | Replimune Group, Inc. | $202k 25,105 shares | -7% | +33% from low-38% from high | |
| 15Weak | Replimune Group, Inc. | $124k 10,000 shares | -5% | - | |
| 13Weak | Revolution Medicines, Inc. | $271k 5,000 shares | -20% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 26, 2025 | RVMD Revolution Medicines, Inc. | AGrant or award Common Stock | +3,142 | $0.00 | $0 | 23,090 | Jun 30, 2025 |
| Jun 26, 2025 | RVMD Revolution Medicines, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +11,574 | $0.00 | $0 | 11,574 | Jun 30, 2025 |
| May 20, 2025 | REPL Replimune Group, Inc. | SOpen-market sale Common Stock | -25,105 | $8.06 | $202k | 343,576 | May 22, 2025 |
| Apr 1, 2025 | REPL Replimune Group, Inc. | AGrant or award Common Stock | +166,667 | $0.00 | $0 | 368,681 | Apr 3, 2025 |
| Apr 1, 2025 | REPL Replimune Group, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +250,000 | $0.00 | $0 | 250,000 | Apr 3, 2025 |
| Dec 16, 2024 | REPL Replimune Group, Inc. | SOpen-market sale Common Stock10b5-1 | -10,000 | $12.42 | $124k | 202,014 | Dec 18, 2024 |
| Oct 31, 2024 | RVMD Revolution Medicines, Inc. | MOption exercise Common Stock10b5-1 | +5,000 | $24.84 | $124k | 24,948 | Nov 4, 2024 |
| Oct 31, 2024 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -5,000 | $54.14 | $271k | 19,948 | Nov 4, 2024 |
| Oct 31, 2024 | RVMD Revolution Medicines, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -5,000 | $0.00 | $0 | 13,400 | Nov 4, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.